Compare Goodyear Tire & Rubber Co (GT) vs Medpace Holdings Inc (MEDP) Price & Performance

Goodyear Tire & Rubber (GT) trades at $4.75, down 1.28% with bearish technical signals. The company faces significant challenges with a net loss of $1.72 billion in 2025 and negative profit margins, though valuation ratios appear attractive with P/E of 4.69 and P/B of 0.48. Recent earnings show mixed results with Q2 2026 beating expectations but still posting losses. Cash flow improved to $46 million in 2025, while debt remains elevated at $7.78 billion total.

The outlook remains challenging with ongoing restructuring efforts and volume pressures. Analyst consensus is mixed with 34.6% buy ratings but a $8.00 price target suggesting 68% upside. Key risks include execution of turnaround plan, competitive pressures, and high debt load. The stock's current valuation discounts much of the negativity, creating potential for recovery if management delivers on margin improvement targets.

Medpace (MEDP) trades at $602.70, down 0.26% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (17.67% net margin, 162.15% ROE). Recent CEO stock sales and mixed institutional activity create near-term uncertainty, though analyst consensus remains positive with a $620.44 price target. The company is scheduled to report Q3 2026 results on October 21, 2026.

MEDP presents a compelling growth story with strong financial metrics, though elevated valuations (P/E 35.41) and insider selling warrant caution. Upside potential exists if Q3 earnings meet expectations, while failure to maintain growth momentum could pressure the stock. The current price near pivot point ($599) suggests balanced risk-reward ahead of earnings.